Medical Care
Global Commercial Drug Manufacturing Service Market Research Report 2025
- Mar 11, 25
- ID: 12799
- Pages: 87
- Figures: 82
- Views: 19
The global market for Commercial Drug Manufacturing Service was valued at US$ 1836 million in the year 2024 and is projected to reach a revised size of US$ 2674 million by 2031, growing at a CAGR of 5.6% during the forecast period.
Commercial drug manufacturing service refers to a series of manufacturing services provided to pharmaceutical companies or research institutions, covering the entire process from drug raw material processing to final product packaging. These services encompass various aspects of drug production, including raw material procurement and inspection, drug formula design and optimization, formulation production and quality control, as well as product packaging and labeling. Commercial Drug Manufacturing Services typically adhere to strict production standards and quality control systems to ensure that the produced drugs meet relevant regulatory requirements and quality standards. Furthermore, these services offer flexible production capabilities and the ability to quickly respond to market changes, helping pharmaceutical companies rapidly launch new drugs or improve existing products to meet market demands. Through Commercial Drug Manufacturing Services, pharmaceutical companies can reduce costs, improve efficiency, and focus on core businesses such as drug research and development and market expansion.
North American market for Commercial Drug Manufacturing Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Commercial Drug Manufacturing Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Commercial Drug Manufacturing Service in Tablet is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Commercial Drug Manufacturing Service include Pyramid Labs, Almac Group, Piramal Pharma, Altasciences, UPM Pharmaceuticals, Aphena Pharma Solutions, Quotient Sciences, Thermo Fisher Scientific, PCI, Torbay Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Commercial Drug Manufacturing Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Commercial Drug Manufacturing Service.
The Commercial Drug Manufacturing Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Commercial Drug Manufacturing Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Commercial Drug Manufacturing Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pyramid Labs
Almac Group
Piramal Pharma
Altasciences
UPM Pharmaceuticals
Aphena Pharma Solutions
Quotient Sciences
Thermo Fisher Scientific
PCI
Torbay Pharma
Experic
Carbogen-Amcis
AbbVie
Alcami
Lonza
Segment by Type
Small Batch Manufacturing Services
Large-Scale Manufacturing Services
Segment by Application
Tablet
Capsule
Inhalation Drug
Biologics
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Commercial Drug Manufacturing Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Commercial drug manufacturing service refers to a series of manufacturing services provided to pharmaceutical companies or research institutions, covering the entire process from drug raw material processing to final product packaging. These services encompass various aspects of drug production, including raw material procurement and inspection, drug formula design and optimization, formulation production and quality control, as well as product packaging and labeling. Commercial Drug Manufacturing Services typically adhere to strict production standards and quality control systems to ensure that the produced drugs meet relevant regulatory requirements and quality standards. Furthermore, these services offer flexible production capabilities and the ability to quickly respond to market changes, helping pharmaceutical companies rapidly launch new drugs or improve existing products to meet market demands. Through Commercial Drug Manufacturing Services, pharmaceutical companies can reduce costs, improve efficiency, and focus on core businesses such as drug research and development and market expansion.
North American market for Commercial Drug Manufacturing Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Commercial Drug Manufacturing Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Commercial Drug Manufacturing Service in Tablet is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Commercial Drug Manufacturing Service include Pyramid Labs, Almac Group, Piramal Pharma, Altasciences, UPM Pharmaceuticals, Aphena Pharma Solutions, Quotient Sciences, Thermo Fisher Scientific, PCI, Torbay Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Commercial Drug Manufacturing Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Commercial Drug Manufacturing Service.
The Commercial Drug Manufacturing Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Commercial Drug Manufacturing Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Commercial Drug Manufacturing Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pyramid Labs
Almac Group
Piramal Pharma
Altasciences
UPM Pharmaceuticals
Aphena Pharma Solutions
Quotient Sciences
Thermo Fisher Scientific
PCI
Torbay Pharma
Experic
Carbogen-Amcis
AbbVie
Alcami
Lonza
Segment by Type
Small Batch Manufacturing Services
Large-Scale Manufacturing Services
Segment by Application
Tablet
Capsule
Inhalation Drug
Biologics
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Commercial Drug Manufacturing Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Commercial Drug Manufacturing Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Small Batch Manufacturing Services
1.2.3 Large-Scale Manufacturing Services
1.3 Market by Application
1.3.1 Global Commercial Drug Manufacturing Service Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Tablet
1.3.3 Capsule
1.3.4 Inhalation Drug
1.3.5 Biologics
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Commercial Drug Manufacturing Service Market Perspective (2020-2031)
2.2 Global Commercial Drug Manufacturing Service Growth Trends by Region
2.2.1 Global Commercial Drug Manufacturing Service Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Commercial Drug Manufacturing Service Historic Market Size by Region (2020-2025)
2.2.3 Commercial Drug Manufacturing Service Forecasted Market Size by Region (2026-2031)
2.3 Commercial Drug Manufacturing Service Market Dynamics
2.3.1 Commercial Drug Manufacturing Service Industry Trends
2.3.2 Commercial Drug Manufacturing Service Market Drivers
2.3.3 Commercial Drug Manufacturing Service Market Challenges
2.3.4 Commercial Drug Manufacturing Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Commercial Drug Manufacturing Service Players by Revenue
3.1.1 Global Top Commercial Drug Manufacturing Service Players by Revenue (2020-2025)
3.1.2 Global Commercial Drug Manufacturing Service Revenue Market Share by Players (2020-2025)
3.2 Global Commercial Drug Manufacturing Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Commercial Drug Manufacturing Service Revenue
3.4 Global Commercial Drug Manufacturing Service Market Concentration Ratio
3.4.1 Global Commercial Drug Manufacturing Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Commercial Drug Manufacturing Service Revenue in 2024
3.5 Global Key Players of Commercial Drug Manufacturing Service Head office and Area Served
3.6 Global Key Players of Commercial Drug Manufacturing Service, Product and Application
3.7 Global Key Players of Commercial Drug Manufacturing Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Commercial Drug Manufacturing Service Breakdown Data by Type
4.1 Global Commercial Drug Manufacturing Service Historic Market Size by Type (2020-2025)
4.2 Global Commercial Drug Manufacturing Service Forecasted Market Size by Type (2026-2031)
5 Commercial Drug Manufacturing Service Breakdown Data by Application
5.1 Global Commercial Drug Manufacturing Service Historic Market Size by Application (2020-2025)
5.2 Global Commercial Drug Manufacturing Service Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Commercial Drug Manufacturing Service Market Size (2020-2031)
6.2 North America Commercial Drug Manufacturing Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Commercial Drug Manufacturing Service Market Size by Country (2020-2025)
6.4 North America Commercial Drug Manufacturing Service Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Commercial Drug Manufacturing Service Market Size (2020-2031)
7.2 Europe Commercial Drug Manufacturing Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Commercial Drug Manufacturing Service Market Size by Country (2020-2025)
7.4 Europe Commercial Drug Manufacturing Service Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Commercial Drug Manufacturing Service Market Size (2020-2031)
8.2 Asia-Pacific Commercial Drug Manufacturing Service Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Commercial Drug Manufacturing Service Market Size by Region (2020-2025)
8.4 Asia-Pacific Commercial Drug Manufacturing Service Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Commercial Drug Manufacturing Service Market Size (2020-2031)
9.2 Latin America Commercial Drug Manufacturing Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Commercial Drug Manufacturing Service Market Size by Country (2020-2025)
9.4 Latin America Commercial Drug Manufacturing Service Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Commercial Drug Manufacturing Service Market Size (2020-2031)
10.2 Middle East & Africa Commercial Drug Manufacturing Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Commercial Drug Manufacturing Service Market Size by Country (2020-2025)
10.4 Middle East & Africa Commercial Drug Manufacturing Service Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pyramid Labs
11.1.1 Pyramid Labs Company Details
11.1.2 Pyramid Labs Business Overview
11.1.3 Pyramid Labs Commercial Drug Manufacturing Service Introduction
11.1.4 Pyramid Labs Revenue in Commercial Drug Manufacturing Service Business (2020-2025)
11.1.5 Pyramid Labs Recent Development
11.2 Almac Group
11.2.1 Almac Group Company Details
11.2.2 Almac Group Business Overview
11.2.3 Almac Group Commercial Drug Manufacturing Service Introduction
11.2.4 Almac Group Revenue in Commercial Drug Manufacturing Service Business (2020-2025)
11.2.5 Almac Group Recent Development
11.3 Piramal Pharma
11.3.1 Piramal Pharma Company Details
11.3.2 Piramal Pharma Business Overview
11.3.3 Piramal Pharma Commercial Drug Manufacturing Service Introduction
11.3.4 Piramal Pharma Revenue in Commercial Drug Manufacturing Service Business (2020-2025)
11.3.5 Piramal Pharma Recent Development
11.4 Altasciences
11.4.1 Altasciences Company Details
11.4.2 Altasciences Business Overview
11.4.3 Altasciences Commercial Drug Manufacturing Service Introduction
11.4.4 Altasciences Revenue in Commercial Drug Manufacturing Service Business (2020-2025)
11.4.5 Altasciences Recent Development
11.5 UPM Pharmaceuticals
11.5.1 UPM Pharmaceuticals Company Details
11.5.2 UPM Pharmaceuticals Business Overview
11.5.3 UPM Pharmaceuticals Commercial Drug Manufacturing Service Introduction
11.5.4 UPM Pharmaceuticals Revenue in Commercial Drug Manufacturing Service Business (2020-2025)
11.5.5 UPM Pharmaceuticals Recent Development
11.6 Aphena Pharma Solutions
11.6.1 Aphena Pharma Solutions Company Details
11.6.2 Aphena Pharma Solutions Business Overview
11.6.3 Aphena Pharma Solutions Commercial Drug Manufacturing Service Introduction
11.6.4 Aphena Pharma Solutions Revenue in Commercial Drug Manufacturing Service Business (2020-2025)
11.6.5 Aphena Pharma Solutions Recent Development
11.7 Quotient Sciences
11.7.1 Quotient Sciences Company Details
11.7.2 Quotient Sciences Business Overview
11.7.3 Quotient Sciences Commercial Drug Manufacturing Service Introduction
11.7.4 Quotient Sciences Revenue in Commercial Drug Manufacturing Service Business (2020-2025)
11.7.5 Quotient Sciences Recent Development
11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Company Details
11.8.2 Thermo Fisher Scientific Business Overview
11.8.3 Thermo Fisher Scientific Commercial Drug Manufacturing Service Introduction
11.8.4 Thermo Fisher Scientific Revenue in Commercial Drug Manufacturing Service Business (2020-2025)
11.8.5 Thermo Fisher Scientific Recent Development
11.9 PCI
11.9.1 PCI Company Details
11.9.2 PCI Business Overview
11.9.3 PCI Commercial Drug Manufacturing Service Introduction
11.9.4 PCI Revenue in Commercial Drug Manufacturing Service Business (2020-2025)
11.9.5 PCI Recent Development
11.10 Torbay Pharma
11.10.1 Torbay Pharma Company Details
11.10.2 Torbay Pharma Business Overview
11.10.3 Torbay Pharma Commercial Drug Manufacturing Service Introduction
11.10.4 Torbay Pharma Revenue in Commercial Drug Manufacturing Service Business (2020-2025)
11.10.5 Torbay Pharma Recent Development
11.11 Experic
11.11.1 Experic Company Details
11.11.2 Experic Business Overview
11.11.3 Experic Commercial Drug Manufacturing Service Introduction
11.11.4 Experic Revenue in Commercial Drug Manufacturing Service Business (2020-2025)
11.11.5 Experic Recent Development
11.12 Carbogen-Amcis
11.12.1 Carbogen-Amcis Company Details
11.12.2 Carbogen-Amcis Business Overview
11.12.3 Carbogen-Amcis Commercial Drug Manufacturing Service Introduction
11.12.4 Carbogen-Amcis Revenue in Commercial Drug Manufacturing Service Business (2020-2025)
11.12.5 Carbogen-Amcis Recent Development
11.13 AbbVie
11.13.1 AbbVie Company Details
11.13.2 AbbVie Business Overview
11.13.3 AbbVie Commercial Drug Manufacturing Service Introduction
11.13.4 AbbVie Revenue in Commercial Drug Manufacturing Service Business (2020-2025)
11.13.5 AbbVie Recent Development
11.14 Alcami
11.14.1 Alcami Company Details
11.14.2 Alcami Business Overview
11.14.3 Alcami Commercial Drug Manufacturing Service Introduction
11.14.4 Alcami Revenue in Commercial Drug Manufacturing Service Business (2020-2025)
11.14.5 Alcami Recent Development
11.15 Lonza
11.15.1 Lonza Company Details
11.15.2 Lonza Business Overview
11.15.3 Lonza Commercial Drug Manufacturing Service Introduction
11.15.4 Lonza Revenue in Commercial Drug Manufacturing Service Business (2020-2025)
11.15.5 Lonza Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Commercial Drug Manufacturing Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Small Batch Manufacturing Services
1.2.3 Large-Scale Manufacturing Services
1.3 Market by Application
1.3.1 Global Commercial Drug Manufacturing Service Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Tablet
1.3.3 Capsule
1.3.4 Inhalation Drug
1.3.5 Biologics
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Commercial Drug Manufacturing Service Market Perspective (2020-2031)
2.2 Global Commercial Drug Manufacturing Service Growth Trends by Region
2.2.1 Global Commercial Drug Manufacturing Service Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Commercial Drug Manufacturing Service Historic Market Size by Region (2020-2025)
2.2.3 Commercial Drug Manufacturing Service Forecasted Market Size by Region (2026-2031)
2.3 Commercial Drug Manufacturing Service Market Dynamics
2.3.1 Commercial Drug Manufacturing Service Industry Trends
2.3.2 Commercial Drug Manufacturing Service Market Drivers
2.3.3 Commercial Drug Manufacturing Service Market Challenges
2.3.4 Commercial Drug Manufacturing Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Commercial Drug Manufacturing Service Players by Revenue
3.1.1 Global Top Commercial Drug Manufacturing Service Players by Revenue (2020-2025)
3.1.2 Global Commercial Drug Manufacturing Service Revenue Market Share by Players (2020-2025)
3.2 Global Commercial Drug Manufacturing Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Commercial Drug Manufacturing Service Revenue
3.4 Global Commercial Drug Manufacturing Service Market Concentration Ratio
3.4.1 Global Commercial Drug Manufacturing Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Commercial Drug Manufacturing Service Revenue in 2024
3.5 Global Key Players of Commercial Drug Manufacturing Service Head office and Area Served
3.6 Global Key Players of Commercial Drug Manufacturing Service, Product and Application
3.7 Global Key Players of Commercial Drug Manufacturing Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Commercial Drug Manufacturing Service Breakdown Data by Type
4.1 Global Commercial Drug Manufacturing Service Historic Market Size by Type (2020-2025)
4.2 Global Commercial Drug Manufacturing Service Forecasted Market Size by Type (2026-2031)
5 Commercial Drug Manufacturing Service Breakdown Data by Application
5.1 Global Commercial Drug Manufacturing Service Historic Market Size by Application (2020-2025)
5.2 Global Commercial Drug Manufacturing Service Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Commercial Drug Manufacturing Service Market Size (2020-2031)
6.2 North America Commercial Drug Manufacturing Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Commercial Drug Manufacturing Service Market Size by Country (2020-2025)
6.4 North America Commercial Drug Manufacturing Service Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Commercial Drug Manufacturing Service Market Size (2020-2031)
7.2 Europe Commercial Drug Manufacturing Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Commercial Drug Manufacturing Service Market Size by Country (2020-2025)
7.4 Europe Commercial Drug Manufacturing Service Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Commercial Drug Manufacturing Service Market Size (2020-2031)
8.2 Asia-Pacific Commercial Drug Manufacturing Service Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Commercial Drug Manufacturing Service Market Size by Region (2020-2025)
8.4 Asia-Pacific Commercial Drug Manufacturing Service Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Commercial Drug Manufacturing Service Market Size (2020-2031)
9.2 Latin America Commercial Drug Manufacturing Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Commercial Drug Manufacturing Service Market Size by Country (2020-2025)
9.4 Latin America Commercial Drug Manufacturing Service Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Commercial Drug Manufacturing Service Market Size (2020-2031)
10.2 Middle East & Africa Commercial Drug Manufacturing Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Commercial Drug Manufacturing Service Market Size by Country (2020-2025)
10.4 Middle East & Africa Commercial Drug Manufacturing Service Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pyramid Labs
11.1.1 Pyramid Labs Company Details
11.1.2 Pyramid Labs Business Overview
11.1.3 Pyramid Labs Commercial Drug Manufacturing Service Introduction
11.1.4 Pyramid Labs Revenue in Commercial Drug Manufacturing Service Business (2020-2025)
11.1.5 Pyramid Labs Recent Development
11.2 Almac Group
11.2.1 Almac Group Company Details
11.2.2 Almac Group Business Overview
11.2.3 Almac Group Commercial Drug Manufacturing Service Introduction
11.2.4 Almac Group Revenue in Commercial Drug Manufacturing Service Business (2020-2025)
11.2.5 Almac Group Recent Development
11.3 Piramal Pharma
11.3.1 Piramal Pharma Company Details
11.3.2 Piramal Pharma Business Overview
11.3.3 Piramal Pharma Commercial Drug Manufacturing Service Introduction
11.3.4 Piramal Pharma Revenue in Commercial Drug Manufacturing Service Business (2020-2025)
11.3.5 Piramal Pharma Recent Development
11.4 Altasciences
11.4.1 Altasciences Company Details
11.4.2 Altasciences Business Overview
11.4.3 Altasciences Commercial Drug Manufacturing Service Introduction
11.4.4 Altasciences Revenue in Commercial Drug Manufacturing Service Business (2020-2025)
11.4.5 Altasciences Recent Development
11.5 UPM Pharmaceuticals
11.5.1 UPM Pharmaceuticals Company Details
11.5.2 UPM Pharmaceuticals Business Overview
11.5.3 UPM Pharmaceuticals Commercial Drug Manufacturing Service Introduction
11.5.4 UPM Pharmaceuticals Revenue in Commercial Drug Manufacturing Service Business (2020-2025)
11.5.5 UPM Pharmaceuticals Recent Development
11.6 Aphena Pharma Solutions
11.6.1 Aphena Pharma Solutions Company Details
11.6.2 Aphena Pharma Solutions Business Overview
11.6.3 Aphena Pharma Solutions Commercial Drug Manufacturing Service Introduction
11.6.4 Aphena Pharma Solutions Revenue in Commercial Drug Manufacturing Service Business (2020-2025)
11.6.5 Aphena Pharma Solutions Recent Development
11.7 Quotient Sciences
11.7.1 Quotient Sciences Company Details
11.7.2 Quotient Sciences Business Overview
11.7.3 Quotient Sciences Commercial Drug Manufacturing Service Introduction
11.7.4 Quotient Sciences Revenue in Commercial Drug Manufacturing Service Business (2020-2025)
11.7.5 Quotient Sciences Recent Development
11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Company Details
11.8.2 Thermo Fisher Scientific Business Overview
11.8.3 Thermo Fisher Scientific Commercial Drug Manufacturing Service Introduction
11.8.4 Thermo Fisher Scientific Revenue in Commercial Drug Manufacturing Service Business (2020-2025)
11.8.5 Thermo Fisher Scientific Recent Development
11.9 PCI
11.9.1 PCI Company Details
11.9.2 PCI Business Overview
11.9.3 PCI Commercial Drug Manufacturing Service Introduction
11.9.4 PCI Revenue in Commercial Drug Manufacturing Service Business (2020-2025)
11.9.5 PCI Recent Development
11.10 Torbay Pharma
11.10.1 Torbay Pharma Company Details
11.10.2 Torbay Pharma Business Overview
11.10.3 Torbay Pharma Commercial Drug Manufacturing Service Introduction
11.10.4 Torbay Pharma Revenue in Commercial Drug Manufacturing Service Business (2020-2025)
11.10.5 Torbay Pharma Recent Development
11.11 Experic
11.11.1 Experic Company Details
11.11.2 Experic Business Overview
11.11.3 Experic Commercial Drug Manufacturing Service Introduction
11.11.4 Experic Revenue in Commercial Drug Manufacturing Service Business (2020-2025)
11.11.5 Experic Recent Development
11.12 Carbogen-Amcis
11.12.1 Carbogen-Amcis Company Details
11.12.2 Carbogen-Amcis Business Overview
11.12.3 Carbogen-Amcis Commercial Drug Manufacturing Service Introduction
11.12.4 Carbogen-Amcis Revenue in Commercial Drug Manufacturing Service Business (2020-2025)
11.12.5 Carbogen-Amcis Recent Development
11.13 AbbVie
11.13.1 AbbVie Company Details
11.13.2 AbbVie Business Overview
11.13.3 AbbVie Commercial Drug Manufacturing Service Introduction
11.13.4 AbbVie Revenue in Commercial Drug Manufacturing Service Business (2020-2025)
11.13.5 AbbVie Recent Development
11.14 Alcami
11.14.1 Alcami Company Details
11.14.2 Alcami Business Overview
11.14.3 Alcami Commercial Drug Manufacturing Service Introduction
11.14.4 Alcami Revenue in Commercial Drug Manufacturing Service Business (2020-2025)
11.14.5 Alcami Recent Development
11.15 Lonza
11.15.1 Lonza Company Details
11.15.2 Lonza Business Overview
11.15.3 Lonza Commercial Drug Manufacturing Service Introduction
11.15.4 Lonza Revenue in Commercial Drug Manufacturing Service Business (2020-2025)
11.15.5 Lonza Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Commercial Drug Manufacturing Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Small Batch Manufacturing Services
Table 3. Key Players of Large-Scale Manufacturing Services
Table 4. Global Commercial Drug Manufacturing Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Commercial Drug Manufacturing Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Commercial Drug Manufacturing Service Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Commercial Drug Manufacturing Service Market Share by Region (2020-2025)
Table 8. Global Commercial Drug Manufacturing Service Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Commercial Drug Manufacturing Service Market Share by Region (2026-2031)
Table 10. Commercial Drug Manufacturing Service Market Trends
Table 11. Commercial Drug Manufacturing Service Market Drivers
Table 12. Commercial Drug Manufacturing Service Market Challenges
Table 13. Commercial Drug Manufacturing Service Market Restraints
Table 14. Global Commercial Drug Manufacturing Service Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Commercial Drug Manufacturing Service Market Share by Players (2020-2025)
Table 16. Global Top Commercial Drug Manufacturing Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Commercial Drug Manufacturing Service as of 2024)
Table 17. Ranking of Global Top Commercial Drug Manufacturing Service Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Commercial Drug Manufacturing Service Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Commercial Drug Manufacturing Service, Headquarters and Area Served
Table 20. Global Key Players of Commercial Drug Manufacturing Service, Product and Application
Table 21. Global Key Players of Commercial Drug Manufacturing Service, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Commercial Drug Manufacturing Service Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Commercial Drug Manufacturing Service Revenue Market Share by Type (2020-2025)
Table 25. Global Commercial Drug Manufacturing Service Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Commercial Drug Manufacturing Service Revenue Market Share by Type (2026-2031)
Table 27. Global Commercial Drug Manufacturing Service Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Commercial Drug Manufacturing Service Revenue Market Share by Application (2020-2025)
Table 29. Global Commercial Drug Manufacturing Service Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Commercial Drug Manufacturing Service Revenue Market Share by Application (2026-2031)
Table 31. North America Commercial Drug Manufacturing Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Commercial Drug Manufacturing Service Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Commercial Drug Manufacturing Service Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Commercial Drug Manufacturing Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Commercial Drug Manufacturing Service Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Commercial Drug Manufacturing Service Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Commercial Drug Manufacturing Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Commercial Drug Manufacturing Service Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Commercial Drug Manufacturing Service Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Commercial Drug Manufacturing Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Commercial Drug Manufacturing Service Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Commercial Drug Manufacturing Service Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Commercial Drug Manufacturing Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Commercial Drug Manufacturing Service Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Commercial Drug Manufacturing Service Market Size by Country (2026-2031) & (US$ Million)
Table 46. Pyramid Labs Company Details
Table 47. Pyramid Labs Business Overview
Table 48. Pyramid Labs Commercial Drug Manufacturing Service Product
Table 49. Pyramid Labs Revenue in Commercial Drug Manufacturing Service Business (2020-2025) & (US$ Million)
Table 50. Pyramid Labs Recent Development
Table 51. Almac Group Company Details
Table 52. Almac Group Business Overview
Table 53. Almac Group Commercial Drug Manufacturing Service Product
Table 54. Almac Group Revenue in Commercial Drug Manufacturing Service Business (2020-2025) & (US$ Million)
Table 55. Almac Group Recent Development
Table 56. Piramal Pharma Company Details
Table 57. Piramal Pharma Business Overview
Table 58. Piramal Pharma Commercial Drug Manufacturing Service Product
Table 59. Piramal Pharma Revenue in Commercial Drug Manufacturing Service Business (2020-2025) & (US$ Million)
Table 60. Piramal Pharma Recent Development
Table 61. Altasciences Company Details
Table 62. Altasciences Business Overview
Table 63. Altasciences Commercial Drug Manufacturing Service Product
Table 64. Altasciences Revenue in Commercial Drug Manufacturing Service Business (2020-2025) & (US$ Million)
Table 65. Altasciences Recent Development
Table 66. UPM Pharmaceuticals Company Details
Table 67. UPM Pharmaceuticals Business Overview
Table 68. UPM Pharmaceuticals Commercial Drug Manufacturing Service Product
Table 69. UPM Pharmaceuticals Revenue in Commercial Drug Manufacturing Service Business (2020-2025) & (US$ Million)
Table 70. UPM Pharmaceuticals Recent Development
Table 71. Aphena Pharma Solutions Company Details
Table 72. Aphena Pharma Solutions Business Overview
Table 73. Aphena Pharma Solutions Commercial Drug Manufacturing Service Product
Table 74. Aphena Pharma Solutions Revenue in Commercial Drug Manufacturing Service Business (2020-2025) & (US$ Million)
Table 75. Aphena Pharma Solutions Recent Development
Table 76. Quotient Sciences Company Details
Table 77. Quotient Sciences Business Overview
Table 78. Quotient Sciences Commercial Drug Manufacturing Service Product
Table 79. Quotient Sciences Revenue in Commercial Drug Manufacturing Service Business (2020-2025) & (US$ Million)
Table 80. Quotient Sciences Recent Development
Table 81. Thermo Fisher Scientific Company Details
Table 82. Thermo Fisher Scientific Business Overview
Table 83. Thermo Fisher Scientific Commercial Drug Manufacturing Service Product
Table 84. Thermo Fisher Scientific Revenue in Commercial Drug Manufacturing Service Business (2020-2025) & (US$ Million)
Table 85. Thermo Fisher Scientific Recent Development
Table 86. PCI Company Details
Table 87. PCI Business Overview
Table 88. PCI Commercial Drug Manufacturing Service Product
Table 89. PCI Revenue in Commercial Drug Manufacturing Service Business (2020-2025) & (US$ Million)
Table 90. PCI Recent Development
Table 91. Torbay Pharma Company Details
Table 92. Torbay Pharma Business Overview
Table 93. Torbay Pharma Commercial Drug Manufacturing Service Product
Table 94. Torbay Pharma Revenue in Commercial Drug Manufacturing Service Business (2020-2025) & (US$ Million)
Table 95. Torbay Pharma Recent Development
Table 96. Experic Company Details
Table 97. Experic Business Overview
Table 98. Experic Commercial Drug Manufacturing Service Product
Table 99. Experic Revenue in Commercial Drug Manufacturing Service Business (2020-2025) & (US$ Million)
Table 100. Experic Recent Development
Table 101. Carbogen-Amcis Company Details
Table 102. Carbogen-Amcis Business Overview
Table 103. Carbogen-Amcis Commercial Drug Manufacturing Service Product
Table 104. Carbogen-Amcis Revenue in Commercial Drug Manufacturing Service Business (2020-2025) & (US$ Million)
Table 105. Carbogen-Amcis Recent Development
Table 106. AbbVie Company Details
Table 107. AbbVie Business Overview
Table 108. AbbVie Commercial Drug Manufacturing Service Product
Table 109. AbbVie Revenue in Commercial Drug Manufacturing Service Business (2020-2025) & (US$ Million)
Table 110. AbbVie Recent Development
Table 111. Alcami Company Details
Table 112. Alcami Business Overview
Table 113. Alcami Commercial Drug Manufacturing Service Product
Table 114. Alcami Revenue in Commercial Drug Manufacturing Service Business (2020-2025) & (US$ Million)
Table 115. Alcami Recent Development
Table 116. Lonza Company Details
Table 117. Lonza Business Overview
Table 118. Lonza Commercial Drug Manufacturing Service Product
Table 119. Lonza Revenue in Commercial Drug Manufacturing Service Business (2020-2025) & (US$ Million)
Table 120. Lonza Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
Table 124. Authors List of This Report
List of Figures
Figure 1. Commercial Drug Manufacturing Service Picture
Figure 2. Global Commercial Drug Manufacturing Service Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Commercial Drug Manufacturing Service Market Share by Type: 2024 VS 2031
Figure 4. Small Batch Manufacturing Services Features
Figure 5. Large-Scale Manufacturing Services Features
Figure 6. Global Commercial Drug Manufacturing Service Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Commercial Drug Manufacturing Service Market Share by Application: 2024 VS 2031
Figure 8. Tablet Case Studies
Figure 9. Capsule Case Studies
Figure 10. Inhalation Drug Case Studies
Figure 11. Biologics Case Studies
Figure 12. Others Case Studies
Figure 13. Commercial Drug Manufacturing Service Report Years Considered
Figure 14. Global Commercial Drug Manufacturing Service Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Commercial Drug Manufacturing Service Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Commercial Drug Manufacturing Service Market Share by Region: 2024 VS 2031
Figure 17. Global Commercial Drug Manufacturing Service Market Share by Players in 2024
Figure 18. Global Top Commercial Drug Manufacturing Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Commercial Drug Manufacturing Service as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Commercial Drug Manufacturing Service Revenue in 2024
Figure 20. North America Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Commercial Drug Manufacturing Service Market Share by Country (2020-2031)
Figure 22. United States Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Commercial Drug Manufacturing Service Market Share by Country (2020-2031)
Figure 26. Germany Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Commercial Drug Manufacturing Service Market Share by Region (2020-2031)
Figure 34. China Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Commercial Drug Manufacturing Service Market Share by Country (2020-2031)
Figure 42. Mexico Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Commercial Drug Manufacturing Service Market Share by Country (2020-2031)
Figure 46. Turkey Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Pyramid Labs Revenue Growth Rate in Commercial Drug Manufacturing Service Business (2020-2025)
Figure 50. Almac Group Revenue Growth Rate in Commercial Drug Manufacturing Service Business (2020-2025)
Figure 51. Piramal Pharma Revenue Growth Rate in Commercial Drug Manufacturing Service Business (2020-2025)
Figure 52. Altasciences Revenue Growth Rate in Commercial Drug Manufacturing Service Business (2020-2025)
Figure 53. UPM Pharmaceuticals Revenue Growth Rate in Commercial Drug Manufacturing Service Business (2020-2025)
Figure 54. Aphena Pharma Solutions Revenue Growth Rate in Commercial Drug Manufacturing Service Business (2020-2025)
Figure 55. Quotient Sciences Revenue Growth Rate in Commercial Drug Manufacturing Service Business (2020-2025)
Figure 56. Thermo Fisher Scientific Revenue Growth Rate in Commercial Drug Manufacturing Service Business (2020-2025)
Figure 57. PCI Revenue Growth Rate in Commercial Drug Manufacturing Service Business (2020-2025)
Figure 58. Torbay Pharma Revenue Growth Rate in Commercial Drug Manufacturing Service Business (2020-2025)
Figure 59. Experic Revenue Growth Rate in Commercial Drug Manufacturing Service Business (2020-2025)
Figure 60. Carbogen-Amcis Revenue Growth Rate in Commercial Drug Manufacturing Service Business (2020-2025)
Figure 61. AbbVie Revenue Growth Rate in Commercial Drug Manufacturing Service Business (2020-2025)
Figure 62. Alcami Revenue Growth Rate in Commercial Drug Manufacturing Service Business (2020-2025)
Figure 63. Lonza Revenue Growth Rate in Commercial Drug Manufacturing Service Business (2020-2025)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Table 1. Global Commercial Drug Manufacturing Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Small Batch Manufacturing Services
Table 3. Key Players of Large-Scale Manufacturing Services
Table 4. Global Commercial Drug Manufacturing Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Commercial Drug Manufacturing Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Commercial Drug Manufacturing Service Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Commercial Drug Manufacturing Service Market Share by Region (2020-2025)
Table 8. Global Commercial Drug Manufacturing Service Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Commercial Drug Manufacturing Service Market Share by Region (2026-2031)
Table 10. Commercial Drug Manufacturing Service Market Trends
Table 11. Commercial Drug Manufacturing Service Market Drivers
Table 12. Commercial Drug Manufacturing Service Market Challenges
Table 13. Commercial Drug Manufacturing Service Market Restraints
Table 14. Global Commercial Drug Manufacturing Service Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Commercial Drug Manufacturing Service Market Share by Players (2020-2025)
Table 16. Global Top Commercial Drug Manufacturing Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Commercial Drug Manufacturing Service as of 2024)
Table 17. Ranking of Global Top Commercial Drug Manufacturing Service Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Commercial Drug Manufacturing Service Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Commercial Drug Manufacturing Service, Headquarters and Area Served
Table 20. Global Key Players of Commercial Drug Manufacturing Service, Product and Application
Table 21. Global Key Players of Commercial Drug Manufacturing Service, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Commercial Drug Manufacturing Service Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Commercial Drug Manufacturing Service Revenue Market Share by Type (2020-2025)
Table 25. Global Commercial Drug Manufacturing Service Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Commercial Drug Manufacturing Service Revenue Market Share by Type (2026-2031)
Table 27. Global Commercial Drug Manufacturing Service Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Commercial Drug Manufacturing Service Revenue Market Share by Application (2020-2025)
Table 29. Global Commercial Drug Manufacturing Service Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Commercial Drug Manufacturing Service Revenue Market Share by Application (2026-2031)
Table 31. North America Commercial Drug Manufacturing Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Commercial Drug Manufacturing Service Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Commercial Drug Manufacturing Service Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Commercial Drug Manufacturing Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Commercial Drug Manufacturing Service Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Commercial Drug Manufacturing Service Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Commercial Drug Manufacturing Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Commercial Drug Manufacturing Service Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Commercial Drug Manufacturing Service Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Commercial Drug Manufacturing Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Commercial Drug Manufacturing Service Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Commercial Drug Manufacturing Service Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Commercial Drug Manufacturing Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Commercial Drug Manufacturing Service Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Commercial Drug Manufacturing Service Market Size by Country (2026-2031) & (US$ Million)
Table 46. Pyramid Labs Company Details
Table 47. Pyramid Labs Business Overview
Table 48. Pyramid Labs Commercial Drug Manufacturing Service Product
Table 49. Pyramid Labs Revenue in Commercial Drug Manufacturing Service Business (2020-2025) & (US$ Million)
Table 50. Pyramid Labs Recent Development
Table 51. Almac Group Company Details
Table 52. Almac Group Business Overview
Table 53. Almac Group Commercial Drug Manufacturing Service Product
Table 54. Almac Group Revenue in Commercial Drug Manufacturing Service Business (2020-2025) & (US$ Million)
Table 55. Almac Group Recent Development
Table 56. Piramal Pharma Company Details
Table 57. Piramal Pharma Business Overview
Table 58. Piramal Pharma Commercial Drug Manufacturing Service Product
Table 59. Piramal Pharma Revenue in Commercial Drug Manufacturing Service Business (2020-2025) & (US$ Million)
Table 60. Piramal Pharma Recent Development
Table 61. Altasciences Company Details
Table 62. Altasciences Business Overview
Table 63. Altasciences Commercial Drug Manufacturing Service Product
Table 64. Altasciences Revenue in Commercial Drug Manufacturing Service Business (2020-2025) & (US$ Million)
Table 65. Altasciences Recent Development
Table 66. UPM Pharmaceuticals Company Details
Table 67. UPM Pharmaceuticals Business Overview
Table 68. UPM Pharmaceuticals Commercial Drug Manufacturing Service Product
Table 69. UPM Pharmaceuticals Revenue in Commercial Drug Manufacturing Service Business (2020-2025) & (US$ Million)
Table 70. UPM Pharmaceuticals Recent Development
Table 71. Aphena Pharma Solutions Company Details
Table 72. Aphena Pharma Solutions Business Overview
Table 73. Aphena Pharma Solutions Commercial Drug Manufacturing Service Product
Table 74. Aphena Pharma Solutions Revenue in Commercial Drug Manufacturing Service Business (2020-2025) & (US$ Million)
Table 75. Aphena Pharma Solutions Recent Development
Table 76. Quotient Sciences Company Details
Table 77. Quotient Sciences Business Overview
Table 78. Quotient Sciences Commercial Drug Manufacturing Service Product
Table 79. Quotient Sciences Revenue in Commercial Drug Manufacturing Service Business (2020-2025) & (US$ Million)
Table 80. Quotient Sciences Recent Development
Table 81. Thermo Fisher Scientific Company Details
Table 82. Thermo Fisher Scientific Business Overview
Table 83. Thermo Fisher Scientific Commercial Drug Manufacturing Service Product
Table 84. Thermo Fisher Scientific Revenue in Commercial Drug Manufacturing Service Business (2020-2025) & (US$ Million)
Table 85. Thermo Fisher Scientific Recent Development
Table 86. PCI Company Details
Table 87. PCI Business Overview
Table 88. PCI Commercial Drug Manufacturing Service Product
Table 89. PCI Revenue in Commercial Drug Manufacturing Service Business (2020-2025) & (US$ Million)
Table 90. PCI Recent Development
Table 91. Torbay Pharma Company Details
Table 92. Torbay Pharma Business Overview
Table 93. Torbay Pharma Commercial Drug Manufacturing Service Product
Table 94. Torbay Pharma Revenue in Commercial Drug Manufacturing Service Business (2020-2025) & (US$ Million)
Table 95. Torbay Pharma Recent Development
Table 96. Experic Company Details
Table 97. Experic Business Overview
Table 98. Experic Commercial Drug Manufacturing Service Product
Table 99. Experic Revenue in Commercial Drug Manufacturing Service Business (2020-2025) & (US$ Million)
Table 100. Experic Recent Development
Table 101. Carbogen-Amcis Company Details
Table 102. Carbogen-Amcis Business Overview
Table 103. Carbogen-Amcis Commercial Drug Manufacturing Service Product
Table 104. Carbogen-Amcis Revenue in Commercial Drug Manufacturing Service Business (2020-2025) & (US$ Million)
Table 105. Carbogen-Amcis Recent Development
Table 106. AbbVie Company Details
Table 107. AbbVie Business Overview
Table 108. AbbVie Commercial Drug Manufacturing Service Product
Table 109. AbbVie Revenue in Commercial Drug Manufacturing Service Business (2020-2025) & (US$ Million)
Table 110. AbbVie Recent Development
Table 111. Alcami Company Details
Table 112. Alcami Business Overview
Table 113. Alcami Commercial Drug Manufacturing Service Product
Table 114. Alcami Revenue in Commercial Drug Manufacturing Service Business (2020-2025) & (US$ Million)
Table 115. Alcami Recent Development
Table 116. Lonza Company Details
Table 117. Lonza Business Overview
Table 118. Lonza Commercial Drug Manufacturing Service Product
Table 119. Lonza Revenue in Commercial Drug Manufacturing Service Business (2020-2025) & (US$ Million)
Table 120. Lonza Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
Table 124. Authors List of This Report
List of Figures
Figure 1. Commercial Drug Manufacturing Service Picture
Figure 2. Global Commercial Drug Manufacturing Service Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Commercial Drug Manufacturing Service Market Share by Type: 2024 VS 2031
Figure 4. Small Batch Manufacturing Services Features
Figure 5. Large-Scale Manufacturing Services Features
Figure 6. Global Commercial Drug Manufacturing Service Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Commercial Drug Manufacturing Service Market Share by Application: 2024 VS 2031
Figure 8. Tablet Case Studies
Figure 9. Capsule Case Studies
Figure 10. Inhalation Drug Case Studies
Figure 11. Biologics Case Studies
Figure 12. Others Case Studies
Figure 13. Commercial Drug Manufacturing Service Report Years Considered
Figure 14. Global Commercial Drug Manufacturing Service Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Commercial Drug Manufacturing Service Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Commercial Drug Manufacturing Service Market Share by Region: 2024 VS 2031
Figure 17. Global Commercial Drug Manufacturing Service Market Share by Players in 2024
Figure 18. Global Top Commercial Drug Manufacturing Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Commercial Drug Manufacturing Service as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Commercial Drug Manufacturing Service Revenue in 2024
Figure 20. North America Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Commercial Drug Manufacturing Service Market Share by Country (2020-2031)
Figure 22. United States Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Commercial Drug Manufacturing Service Market Share by Country (2020-2031)
Figure 26. Germany Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Commercial Drug Manufacturing Service Market Share by Region (2020-2031)
Figure 34. China Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Commercial Drug Manufacturing Service Market Share by Country (2020-2031)
Figure 42. Mexico Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Commercial Drug Manufacturing Service Market Share by Country (2020-2031)
Figure 46. Turkey Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Commercial Drug Manufacturing Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Pyramid Labs Revenue Growth Rate in Commercial Drug Manufacturing Service Business (2020-2025)
Figure 50. Almac Group Revenue Growth Rate in Commercial Drug Manufacturing Service Business (2020-2025)
Figure 51. Piramal Pharma Revenue Growth Rate in Commercial Drug Manufacturing Service Business (2020-2025)
Figure 52. Altasciences Revenue Growth Rate in Commercial Drug Manufacturing Service Business (2020-2025)
Figure 53. UPM Pharmaceuticals Revenue Growth Rate in Commercial Drug Manufacturing Service Business (2020-2025)
Figure 54. Aphena Pharma Solutions Revenue Growth Rate in Commercial Drug Manufacturing Service Business (2020-2025)
Figure 55. Quotient Sciences Revenue Growth Rate in Commercial Drug Manufacturing Service Business (2020-2025)
Figure 56. Thermo Fisher Scientific Revenue Growth Rate in Commercial Drug Manufacturing Service Business (2020-2025)
Figure 57. PCI Revenue Growth Rate in Commercial Drug Manufacturing Service Business (2020-2025)
Figure 58. Torbay Pharma Revenue Growth Rate in Commercial Drug Manufacturing Service Business (2020-2025)
Figure 59. Experic Revenue Growth Rate in Commercial Drug Manufacturing Service Business (2020-2025)
Figure 60. Carbogen-Amcis Revenue Growth Rate in Commercial Drug Manufacturing Service Business (2020-2025)
Figure 61. AbbVie Revenue Growth Rate in Commercial Drug Manufacturing Service Business (2020-2025)
Figure 62. Alcami Revenue Growth Rate in Commercial Drug Manufacturing Service Business (2020-2025)
Figure 63. Lonza Revenue Growth Rate in Commercial Drug Manufacturing Service Business (2020-2025)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232